This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Howard, O. M. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Howard, O. M. Z.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2003, p. 2810-2816, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.2810-2816.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1

Xin Chen,1 Lu Yang,2 Ning Zhang,3 Jim A. Turpin,4 Robert W. Buckheit,2 Clay Osterling,5 Joost J. Oppenheim,3 and O. M. Zack Howard3*

Basic Research Program, SAIC-Frederick, Inc.,1 Laboratory of Molecular Immunoregulation, National Cancer Institute—Frederick, Frederick, Maryland 21702-1201,3 TherImmune Research Corporation, Gaithersburg, Maryland 20879,2 Howpin International Consulting, Frederick, Maryland 21703,4 Infectious Disease Research Department, Southern Research Institute, Frederick, Maryland 217015

Received 3 December 2002/ Returned for modification 20 February 2003/ Accepted 13 June 2003

Shikonin is a major component of zicao (purple gromwell, the dried root of Lithospermum erythrorhizon), a Chinese herbal medicine with various biological activities, including inhibition of human immunodeficiency virus (HIV) type 1 (HIV-1). G protein-coupled chemokine receptors are used by HIV-1 as coreceptors to enter the host cells. In this study, we assessed the effects of shikonin on chemokine receptor function and HIV-1 replication. The results showed that, at nanomolar concentrations, shikonin inhibited monocyte chemotaxis and calcium flux in response to a variety of CC chemokines (CCL2 [monocyte chemoattractant protein 1], CCL3 [macrophage inflammatory protein 1{alpha}], and CCL5 [regulated upon activation, normal T-cell expressed and secreted protein]), the CXC chemokine (CXCL12 [stromal cell-derived factor 1{alpha}]), and classic chemoattractants (formylmethionyl-leucine-phenylalanine and complement fraction C5a). Shikonin down-regulated surface expression of CCR5, a primary HIV-1 coreceptor, on macrophages to a greater degree than the other receptors (CCR1, CCR2, CXCR4, and the formyl peptide receptor) did. CCR5 mRNA expression was also down-regulated by the compound. Additionally, shikonin inhibited the replication of a multidrug-resistant strain and pediatric clinical isolates of HIV in human peripheral blood mononuclear cells, with 50% inhibitory concentrations (IC50s) ranging from 96 to 366 nM. Shikonin also effectively inhibited the replication of the HIV Ba-L isolate in monocytes/macrophages, with an IC50 of 470 nM. Our results suggest that the anti-HIV and anti-inflammatory activities of shikonin may be related to its interference with chemokine receptor expression and function. Therefore, shikonin, as a naturally occurring, low-molecular-weight pan-chemokine receptor inhibitor, constitutes a basis for the development of novel anti-HIV therapeutic agents.


* Corresponding author. Mailing address: Laboratory of Molecular Immunoregulation, National Cancer Institute—Frederick, B.O. Box B, Bldg. 560/Rm. 31-19, Frederick, MD 21702-1201. Phone: (301) 846-1347. Fax: (301) 846-6752. E-mail: howardz{at}mail.ncifcrf.gov.


Antimicrobial Agents and Chemotherapy, September 2003, p. 2810-2816, Vol. 47, No. 9
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.9.2810-2816.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Wu, S.-J., Qi, J.-L., Zhang, W.-J., Liu, S.-H., Xiao, F.-H., Zhang, M.-S., Xu, G.-H., Zhao, W.-G., Shi, M.-W., Pang, Y.-J., Shen, H.-G., Yang, Y.-H. (2009). Nitric Oxide Regulates Shikonin Formation in Suspension-Cultured Onosma paniculatum Cells. Plant Cell Physiol 50: 118-128 [Abstract] [Full Text]  
  • Aquaro, S., Svicher, V., Schols, D., Pollicita, M., Antinori, A., Balzarini, J., Perno, C. F. (2006). Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies. J. Leukoc. Biol. 80: 1103-1110 [Abstract] [Full Text]